4C	O
-	O
seq	O
revealed	O
long	O
-	O
range	O
interactions	O
of	O
a	O
functional	O
enhancer	O
at	O
the	O
8q24	O
prostate	B-DISEASE
cancer	E-DISEASE
risk	O
locus	O
.	O


Genome	O
-	O
wide	O
association	O
studies	O
(	O
GWAS	O
)	O
have	O
identified	O
>	O
100	O
independent	O
susceptibility	O
loci	O
for	O
prostate	B-DISEASE
cancer	E-DISEASE
,	O
including	O
the	O
hot	O
spot	O
at	O
8q24	O
.	O


However	O
,	O
how	O
genetic	O
variants	O
at	O
this	O
locus	O
confer	O
disease	O
risk	O
hasn	O
'	O
t	O
been	O
fully	O
characterized	O
.	O


Using	O
circularized	O
chromosome	O
conformation	O
capture	O
(	O
4C	O
)	O
coupled	O
with	O
next	O
-	O
generation	O
sequencing	O
and	O
an	O
enhancer	O
at	O
8q24	O
as	O
"	O
bait	O
"	O
,	O
we	O
identified	O
genome	O
-	O
wide	O
partners	O
interacting	O
with	O
this	O
enhancer	O
in	O
cell	O
lines	O
LNCaP	O
and	O
C4	O
-	O
2B	O
.	O


These	O
4C	O
-	O
identified	O
regions	O
are	O
distributed	O
in	O
open	O
nuclear	O
compartments	O
,	O
featuring	O
active	O
histone	O
marks	O
(	O
H3K4me1	O
,	O
H3K4me2	O
and	O
H3K27Ac	O
)	O
.	O


Transcription	O
factors	O
NKX3	O
-	O
1	O
,	O
FOXA1	O
and	O
AR	O
(	O
androgen	O
receptor	O
)	O
tend	O
to	O
occupy	O
these	O
4C	O
regions	O
.	O


We	O
identified	O
genes	O
located	O
at	O
the	O
interacting	O
regions	O
,	O
and	O
found	O
them	O
linked	O
to	O
positive	O
regulation	O
of	O
mesenchymal	O
cell	O
proliferation	O
in	O
LNCaP	O
and	O
C4	O
-	O
2B	O
,	O
and	O
several	O
pathways	O
(	O
TGF	O
beta	O
signaling	O
pathway	O
in	O
LNCaP	O
and	O
p53	O
pathway	O
in	O
C4	O
-	O
2B	O
)	O
.	O


Common	O
genes	O
(	O
e	O
.	O
g	O
.	O
MYC	O
and	O
POU5F1B	O
)	O
were	O
identified	O
in	O
both	O
prostate	O
cancer	O
cell	O
lines	O
.	O


However	O
,	O
each	O
cell	O
line	O
also	O
had	O
exclusive	O
genes	O
(	O
e	O
.	O
g	O
.	O
ELAC2	O
and	O
PTEN	O
in	O
LNCaP	O
and	O
BRCA2	O
and	O
ZFHX3	O
in	O
C4	O
-	O
2B	O
)	O
.	O


In	O
addition	O
,	O
BCL	O
-	O
2	O
identified	O
in	O
C4	O
-	O
2B	O
might	O
contribute	O
to	O
the	O
progression	O
of	O
androgen	O
-	O
refractory	O
prostate	B-DISEASE
cancer	E-DISEASE
.	O


Overall	O
,	O
our	O
work	O
reveals	O
key	O
genes	O
and	O
pathways	O
involved	O
in	O
prostate	B-DISEASE
cancer	E-DISEASE
onset	O
and	O
progression	O
.	O
